Gossamer Bio (NASDAQ: GOSS) awards 115K stock options to director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Gossamer Bio, Inc. director John D. Quisel received a grant of stock options covering 115,000 shares of common stock as board compensation. The options have an exercise price of $0.178 per share and expire on June 3, 2036.
The entire option grant becomes fully vested and exercisable on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, conditioned on his continued board service. This is a routine non-employee director award rather than an open-market share purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Quisel John D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 115,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 115,000 shares (Direct, null)
Footnotes (1)
- Award made pursuant to Non-Employee Director Compensation Program. The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Option grant size: 115,000 shares
Exercise price: $0.178 per share
Expiration date: June 3, 2036
+2 more
5 metrics
Option grant size
115,000 shares
Stock option award to director John D. Quisel
Exercise price
$0.178 per share
Stock option exercise price
Expiration date
June 3, 2036
Option expiration for 115,000-share grant
Shares underlying options
115,000 shares
Common stock underlying granted options
Total derivative holdings after grant
115,000 options
Total options held following this transaction
Key Terms
Non-Employee Director Compensation Program, stock option, vesting, grant date, +1 more
5 terms
Non-Employee Director Compensation Program financial
"Award made pursuant to Non-Employee Director Compensation Program."
stock option financial
"The entire number of shares subject to this option becomes fully vested..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"becomes fully vested and exercisable on the first to occur of (a) the first anniversary..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant date financial
"the first anniversary of the grant date or (b) the next occurring annual meeting..."
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
exercise price financial
"conversion_or_exercise_price": "0.1780""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did Gossamer Bio (GOSS) disclose in this Form 4 filing?
Gossamer Bio disclosed that director John D. Quisel received a stock option grant for 115,000 shares. The award is part of the company’s Non-Employee Director Compensation Program and represents routine equity-based board compensation rather than an open-market transaction.
How many Gossamer Bio (GOSS) options were granted to John D. Quisel?
John D. Quisel was granted options covering 115,000 shares of Gossamer Bio common stock. These options give him the right to buy shares at a fixed price, subject to vesting and expiration terms defined in the company’s director compensation program.
What is the exercise price of the Gossamer Bio (GOSS) options granted?
The stock options granted to John D. Quisel have an exercise price of $0.178 per share. This is the price he must pay per share to acquire Gossamer Bio common stock once the options have vested and before they expire, assuming he chooses to exercise.
When do John D. Quisel’s Gossamer Bio (GOSS) options vest?
All 115,000 options become fully vested and exercisable on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders. Vesting is conditioned on his continued service on Gossamer Bio’s board of directors through the applicable vesting date.
When do the Gossamer Bio (GOSS) options granted to John D. Quisel expire?
The options granted to John D. Quisel expire on June 3, 2036. He can exercise vested options any time before this expiration date, subject to the plan’s terms and his continued eligibility under Gossamer Bio’s Non-Employee Director Compensation Program.